Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
Federal Circuit Affirms Biosimilar Infringement Finding Against Mylan
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., decided by Federal Circuit on March 14, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Mylan's proposed ...